MedTrace Logo

Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"

NCT02068508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1067

Last updated 2019-03-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the safety and efficacy of long-term treatment with pioglitazone (Actos Tablets) in the routine clinical setting in combination with an insulin product in patients with type 2 diabetes mellitus who responded inadequately when using an insulin product in addition to diet therapy and exercise therapy.

Conditions

Interventions

DRUG

Pioglitazone

Pioglitazone Tablets

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-30
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02068508 on ClinicalTrials.gov